Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) EBIT Margin (2021 - 2026)

Updated

Context Therapeutics (CNTX) recorded EBIT Margin of -2400.44% in Q3 2026, down 1127.85 percentage points from -1272.59% a year earlier but up 1174.63 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) EBIT Margin (2021 - 2026) Analysis & Trends

On a TTM basis, Context Therapeutics' EBIT Margin came in at -2359.37% as of Sep 30, 2026, down 1534.03 percentage points year-over-year; for FY2025, it came in at -1175.14%, down 240.08 percentage points from FY2024.

  • Annual EBIT Margin has a three-year change of +1635.40 percentage points (FY2022 to FY2025).
  • Across earlier years, EBIT Margin came in at -935.06% in FY2024 (+1218.99 pp), -2154.05% in FY2023 (+656.49 pp) and -2810.54% in FY2022.
  • Quarterly EBIT Margin has ranged from -981556.83% in Q4 2021 to -367.62% in Q2 2024 over the past five years.
  • On a year-over-year basis, EBIT Margin has declined for four consecutive quarters, with an average year-over-year change of -291.04 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 980372.69 percentage points in Q4 2022, against a drop of 2495.33 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -3575.07% (Q2 2026), -1796.40% (Q1 2026) and -2022.71% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -907.40%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 34.46%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 24.35%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 36.01%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 30.74%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 41.71%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -2,400.44%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2,400.44%
Jun 30, 2026 -3,575.07%
Mar 31, 2026 -1,796.40%
Dec 31, 2025 -2,022.71%
Sep 30, 2025 -1,272.59%
Jun 30, 2025 -1,079.74%
Mar 31, 2025 -576.84%
Dec 31, 2024 -447.12%
Sep 30, 2024 -1,503.71%
Jun 30, 2024 -367.62%
Mar 31, 2024 -2,509.67%
Dec 31, 2023 -3,085.28%
Sep 30, 2023 -2,127.98%
Jun 30, 2023 -1,804.58%
Mar 31, 2023 -1,875.04%
Dec 31, 2022 -1,184.14%
Sep 30, 2022 -2,105.69%
Jun 30, 2022 -18,819.55%
Mar 31, 2022 -58,713.54%
Dec 31, 2021 -981,556.83%
API Access

Context Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CNTX&period=max&api_key=YOUR_API_KEY